George W. Lloyd is VP at Royalty Pharma plc (RPRX). They have made 21 open-market trades across 1 company since 2020, most recently 2025-12-18.
CIK 0001814899
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $398K since 2020, against 20 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RPRX | 30,654 | $1.9M |
Shares reported on the most recent Form 4, priced at the 2025-12-19 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RPRX | SELL · 10b5-1 | 2025-12-17 | 2025-12-19 | $38.56 | $7.3M | +0.9% | +1.5% | +18.2% |
| RPRX | SELL · 10b5-1 | 2025-12-03 | 2025-12-05 | $39.77 | $4.4M | -3.7% | -0.3% | +14.8% |
| RPRX | SELL · 10b5-1 | 2025-11-19 | 2025-11-21 | $38.34 | $10.4M | +0.8% | +0.1% | +16.1% |
| RPRX | SELL | 2023-06-02 | 2023-06-06 | $33.71 | $13.0M | -5.4% | -9.6% | -12.5% |
| RPRX | SELL | 2023-03-28 | 2023-03-30 | $37.05 | $4.7M | -0.5% | -2.6% | -18.4% |
| RPRX | SELL | 2023-02-23 | 2023-02-27 | $37.27 | $1.9M | -6.9% | +1.5% | -9.7% |
| RPRX | SELL | 2022-11-21 | 2022-11-22 | $43.14 | $3.2M | -0.7% | -9.5% | -13.9% |
| RPRX | SELL | 2022-11-10 | 2022-11-14 | $43.85 | $1.1M | +1.4% | -2.1% | -10.3% |
| RPRX | SELL | 2022-08-09 | 2022-08-11 | $43.92 | $1.8M | -0.6% | -0.1% | -1.5% |
| RPRX | SELL | 2022-07-28 | 2022-08-01 | $43.97 | $356K | +2.6% | -1.9% | -0.7% |
| RPRX | SELL | 2022-07-25 | 2022-07-27 | $43.15 | $5.4M | -1.0% | -1.1% | -4.9% |
| RPRX | SELL | 2022-05-26 | 2022-05-31 | $40.29 | $8.1M | -1.6% | +2.2% | +2.9% |
| RPRX | SELL | 2022-05-23 | 2022-05-25 | $40.27 | $8.1M | +2.0% | +6.6% | +7.2% |
| RPRX | SELL | 2021-11-16 | 2021-11-18 | $42.39 | $21.2M | -7.7% | -8.5% | -3.6% |
| RPRX | SELL | 2021-07-26 | 2021-07-27 | $39.78 | $1.1M | -5.6% | -0.7% | -3.9% |
| RPRX | SELL | 2021-07-12 | 2021-07-14 | $42.01 | $1.9M | -2.9% | -5.3% | -11.8% |
| RPRX | SELL | 2021-07-06 | 2021-07-08 | $42.20 | $7.3M | -0.7% | -11.4% | -14.1% |
| RPRX | SELL | 2021-06-10 | 2021-06-14 | $46.50 | $5.1M | -3.4% | -7.9% | -13.5% |
| RPRX | SELL | 2021-06-04 | 2021-06-08 | $46.15 | $18.6M | -5.4% | -11.1% | -16.2% |
| RPRX | SELL | 2021-06-02 | 2021-06-04 | $42.12 | $2.6M | -4.3% | -8.7% | -13.7% |
| RPRX | SELL | 2021-04-14 | 2021-04-16 | $42.14 | $5.9M | +7.4% | -1.1% | -4.5% |
| RPRX | SELL · 10b5-1 | 2021-04-12 | 2021-04-14 | $42.32 | $19K | +5.7% | -4.2% | -1.7% |
| RPRX | SELL | 2021-03-22 | 2021-03-24 | $46.32 | $5.1M | -1.4% | +1.1% | +1.0% |
| RPRX | SELL | 2021-03-02 | 2021-03-04 | $46.94 | $11.7M | +9.3% | -0.5% | +0.1% |
| RPRX | BUY | 2020-06-18 | 2020-06-22 | $28.00 | $398K | -13.7% | -18.7% | -23.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.